Press release
10.11.2021 To the attention of interested persons EMA starts evaluating use of COVID-19 vaccine Spikevax in children aged 6 to […]
Press release
08.11.2021 To the attention of interested persons COVID-19: EMA and Heads of Medicines Agencies update on molnupiravir; EMA starts review […]
Important notification
08.11.2021 To the attention of all wholesale distributors of medicinal products, authorised in Romania According to Minister of Health no. […]
Important notification
04.11.2021 To the attention of all wholesale distributors of medicinal products, authorised in Romania According to Minister of Health no. […]
Press release
02.11.2021 To the attention of interested persons EMA ends rolling review of the antibodies bamlanivimab and etesevimab for COVID-19 following […]
Important notification
02.11.2021 To the attention of all importers and distributors of medical devices The NAMMDR warns all importers and distributors of […]
Press release
02.11.2021 To the attention of interested persons Questions and answers on end of rolling review for antibodies bamlanivimab and etesevimab […]
Press release
29.10.2021 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021 download […]
Press release
25.10.2021 To the attention of interested persons Spikevax: EMA recommendation on booster download document …
Press release
25.10.2021 To the attention of interested persons COVID-19: EMA starts rolling review of molnupiravir download document …